These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A comparison between iohexol and metrizamide, two nonionic contrast media, in aorto-femoral angiography. Whitehouse GH; Snowdon SL Br J Radiol; 1984 Jan; 57(673):39-42. PubMed ID: 6704647 [TBL] [Abstract][Full Text] [Related]
7. Human pharmacologic trials with iohexol. Aakhus T; Dahlström K; Shaw DD; Leese PT; March L Acta Radiol Suppl; 1983; 366():20-2. PubMed ID: 6433655 [TBL] [Abstract][Full Text] [Related]
8. Tolerability and usefulness of iohexol in cardioangiography. I. An open multicentre clinical trial. Levorstad K; Simonsen S; Skrede M; Orning O; Tylén U; Olsson L; Selin K; Dahlström K; Andrew E Acta Radiol Diagn (Stockh); 1982; 23(6):535-43. PubMed ID: 6763454 [TBL] [Abstract][Full Text] [Related]
9. Comparative trial of iohexol 350, a non-ionic contrast medium, with diatrizoate (Urografin 370) in left ventriculography and coronary arteriography. Sullivan ID; Wainwright RJ; Reidy JF; Sowton E Br Heart J; 1984 Jun; 51(6):643-7. PubMed ID: 6375703 [TBL] [Abstract][Full Text] [Related]
10. Iohexol in patients with previous adverse reactions to contrast media. Holtås S Invest Radiol; 1984; 19(6):563-5. PubMed ID: 6511264 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic effects of iopentol after intravenous injection in healthy volunteers. Preliminary report. Aakhus T; Stokke O; Stormorken H; Berg KJ; Dahlstrøm K Acta Radiol Suppl; 1987; 370():109-12. PubMed ID: 2980303 [TBL] [Abstract][Full Text] [Related]
12. Safety and pharmacokinetics of ioversol in healthy volunteers. Wilkins RA; Whittington JR; Brigden GS; Lahiri A; Heber ME; Hughes LO Invest Radiol; 1989 Oct; 24(10):781-8. PubMed ID: 2793391 [TBL] [Abstract][Full Text] [Related]
14. Safety and toleration of the non-ionic contrast medium iopentol. An intravenous phase I trial. Jakobsen JA; Hagve TA; Holager T; Waaler A; Haider T; Andrew E; Aakhus T Eur J Radiol; 1989 Nov; 9(4):203-7. PubMed ID: 2591384 [TBL] [Abstract][Full Text] [Related]
15. Complications in cerebral angiography. A comparison between the non-ionic contrast medium iohexol and meglumine metrizoate (Isopaque Cerebral). Skalpe IO; Anke IM Neuroradiology; 1983; 25(3):157-60. PubMed ID: 6350922 [TBL] [Abstract][Full Text] [Related]
16. Iohexol in coronary angiography. A double blind investigation. Orjavik OS; Orning OM; Skrede M; Andrew E Acta Radiol Diagn (Stockh); 1984; 25(3):243-8. PubMed ID: 6475561 [TBL] [Abstract][Full Text] [Related]
17. Tolerance and excretion of iohexol after intravenous injection in healthy volunteers. Preliminary report. Aakhus T; Sommerfelt SC; Stormorken H; Dahlström K Acta Radiol Suppl; 1980; 362():131-4. PubMed ID: 6267886 [No Abstract] [Full Text] [Related]
18. Proteinuria following nephroangiography. VIII. Comparison between diatrizoate and iohexol in the rat. Holtås S; Golman K; Törnquist C Acta Radiol Suppl; 1980; 362():53-5. PubMed ID: 6267894 [TBL] [Abstract][Full Text] [Related]
19. A controlled clinical trial of iohexol and diatrizoate in aortofemoral angiography. Egsgaard H; Hørup A; Praestholm J Eur J Radiol; 1983 Feb; 3(1):14-7. PubMed ID: 6341063 [TBL] [Abstract][Full Text] [Related]
20. Psychic changes following myelography with metrizamide and iohexol. A comparative investigation with psychologic tests. Cronqvist SE; Holtås SL; Laike T; Ozolins A Acta Radiol Diagn (Stockh); 1984; 25(5):369-73. PubMed ID: 6507132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]